SCHEMBL6972359

SCHEMBL6972359

CCc1cc(Cc2c[nH]c(OC(=O)/C=C/C(=O)Oc3nc(Cc4cc(CC)sc4CC)c[nH]3)n2)c(CC)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6972184 0.81 — —
SCHEMBL6972068 0.80 — —
SCHEMBL6971274 0.74 MAPT (0.30) —
SCHEMBL6969272 0.73 LMNA (0.30) —
SCHEMBL6969777 0.72 — —
SCHEMBL6960371 0.68 — —
SCHEMBL1977080 0.66 MEN1 (0.30) —
SCHEMBL7809154 0.65 ADRA1D (0.33) —
SCHEMBL6901097 0.64 ALDH1A1 (0.37) —
SCHEMBL6963180 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0954521-B1 4- (THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING ALPHA2-ADRENOCEPTOR AGONISTIC ACTIVITY ORTHO MCNEIL PHARM INC (US) 2003-05-14 — — EP disclosed
US-5750720-A ALPHA-ADRENORECEPTORS AND CENTRAL NERVOUS SYSTEMS ORTHO PHARMACEUTICAL CORPORATION (US) 1998-05-12 — — US disclosed
Send feedback